These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9005789)

  • 21. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.
    Klossek JM; Siegert R; Nikolaidis P; Arvis P; Leberre MA;
    J Laryngol Otol; 2003 Jan; 117(1):43-51. PubMed ID: 12590855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of ofloxacin in infections which do not readily respond to treatment].
    Zalaudek G
    Antibiot Khimioter; 1996; 41(9):11-2. PubMed ID: 9005779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanisms of resistance to quinolones and current level of sensitivity of clinically important microorganisms to ofloxacin].
    Sidorenko SV; Rezvan SP; Makarova RA; Makarov AN; Kozlova NS; Ogneva NS; Korolev IuS; Gladin DP
    Antibiot Khimioter; 1996; 41(9):33-8. PubMed ID: 9005782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness of pefloxacin in the surgical clinic].
    Iakovlev VP; Blatun LA; Khlebnikov EP; Elagina LV; Puchkova LS
    Antibiot Khimioter; 1995 Aug; 40(8):43-5. PubMed ID: 8713438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Are the principles of treatment of chronic osteitis applicable to the diabetic foot?].
    Senneville E; Yazdanpanah Y; Cordonnier M; Cazaubiel M; Lepeut M; Baclet V; Beltrand E; Khazarjian A; Caillaux M; Dubreuil L; Mouton Y
    Presse Med; 2002 Mar; 31(9):393-9. PubMed ID: 11933734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ofloxacin in comprehensive treatment of infections in burn patients].
    Krutikov MG; Alekseev AA; Elagina LV; Izotova GN; Iakovlev VP
    Antibiot Khimioter; 1996; 41(9):77-80. PubMed ID: 9005793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of chronic suppurative otitis media and otitis externa with 0.3 per cent ofloxacin otic solution: a clinico-microbiological study.
    Supiyaphun P; Tonsakulrungruang K; Chochaipanichnon L; Chongtateong A; Samart Y
    J Med Assoc Thai; 1995 Jan; 78(1):18-21. PubMed ID: 7622972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ofloxacin treatment of difficult infections of the skin and skin structure.
    Gentry LO; Rodriguez-Gomez G
    Cutis; 1993 Jan; 51(1):55-8. PubMed ID: 8419113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Our experience with ofloxacin in the treatment of osteoarticular infections].
    Lopitaux R; Hermet R; Sirot J; Terver S; Levai JP
    Pathol Biol (Paris); 1988 May; 36(5):557-61. PubMed ID: 3043357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology].
    Derevianko II; Khodyreva LA; Avdoshin VL; Andriukhin MI; Gabliia MIu
    Antibiot Khimioter; 1998; 43(10):36-41. PubMed ID: 9825109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of ofloxacin otic solution with oral amoxycillin plus chloramphenicol ear drop in treatment of chronic suppurative otitis media with acute exacerbation.
    Supiyaphun P; Kerekhanjanarong V; Koranasophonepun J; Sastarasadhit V
    J Med Assoc Thai; 2000 Jan; 83(1):61-8. PubMed ID: 10710871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ofloxacin versus cephalexin in the treatment of skin, skin structure, and soft-tissue infections in adults.
    Powers RD; Schwartz R; Snow RM; Yarbrough DR
    Clin Ther; 1991; 13(6):727-36. PubMed ID: 1790547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of Flexner's dysentery with ofloxacin].
    Rakhmanova AG; Kulikov VP
    Antibiot Khimioter; 1996; 41(9):95. PubMed ID: 9005798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Susceptibility in vitro to certain quinolines of gram-negative bacteria and gram-positive cocci causing urinary tract infections].
    Mróz E; Jankowski S; Bartelmus J; Grzybek-Hryncewicz K; Ruczkowska J; Starek J; Boratyńska M
    Med Dosw Mikrobiol; 1993; 45(1):115-8. PubMed ID: 8231429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ofloxacin otic solution as treatment of chronic suppurative otitis media and diffuse bacterial otitis externa.
    Sumitsawan Y; Tharavichitkul P; Prawatmuang W; Ingsuwan B; Sriburi P
    J Med Assoc Thai; 1995 Sep; 78(9):455-9. PubMed ID: 7561571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical experience with the use of ofloxacin in infections of the upper and lower urinary tracts: demonstrations of the results of clinical trials].
    Liudvig G
    Antibiot Khimioter; 1996; 41(9):84-5. PubMed ID: 9005795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G; Tulunay C
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antibiotic sensitivity of Proteus, Pseudomonas pyocyanea and staphyloccoci isolated from scleroma and ozena patients].
    Krylov IA
    Antibiotiki; 1977 Jan; 22(1):50-3. PubMed ID: 402886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experiences with ofloxacin sequential therapy in chronic ear infections.
    Heppt W; Lutz H
    Eur Arch Otorhinolaryngol; 1993; 250 Suppl 1():S19-21. PubMed ID: 8476581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical safety and efficacy of ofloxacin.
    Marone P; Concia E; Grossi P; Malfitano A; Perversi L
    Chemioterapia; 1988 Oct; 7(5):320-2. PubMed ID: 3224401
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.